NasdaqGS - Nasdaq Real Time Price USD
DexCom, Inc. (DXCM)
82.85
-0.14
(-0.17%)
At close: June 12 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 23 | 23 |
| Avg. Estimate | 0.45 | 0.57 | 2.02 | 2.52 |
| Low Estimate | 0.4 | 0.53 | 1.95 | 2.3 |
| High Estimate | 0.49 | 0.63 | 2.14 | 2.89 |
| Year Ago EPS | 0.43 | 0.45 | 1.64 | 2.02 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 25 | 25 |
| Avg. Estimate | 1.13B | 1.17B | 4.61B | 5.31B |
| Low Estimate | 1.12B | 1.14B | 4.57B | 5.07B |
| High Estimate | 1.15B | 1.2B | 4.68B | 5.59B |
| Year Ago Sales | 1B | 994.2M | 4.03B | 4.61B |
| Sales Growth (year/est) | 12.07% | 17.54% | 14.33% | 15.19% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.39 | 0.43 | 0.5 | 0.33 |
| EPS Actual | 0.43 | 0.45 | 0.45 | 0.32 |
| Difference | 0.04 | 0.02 | -0.05 | -0.01 |
| Surprise % | 11.36% | 3.53% | -9.87% | -2.56% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.45 | 0.57 | 2.02 | 2.52 |
| 7 Days Ago | 0.45 | 0.57 | 2.02 | 2.52 |
| 30 Days Ago | 0.45 | 0.57 | 2.02 | 2.52 |
| 60 Days Ago | 0.48 | 0.55 | 2.02 | 2.47 |
| 90 Days Ago | 0.48 | 0.55 | 2.02 | 2.47 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 17 |
| Up Last 30 Days | 1 | 14 | 10 | 17 |
| Down Last 7 Days | 1 | -- | 1 | 4 |
| Down Last 30 Days | 19 | 4 | 7 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DXCM | 3.59% | 25.64% | 23.43% | 24.25% |
| S&P 500 | 13.13% | 2.45% | 7.55% | 14.06% |
Upgrades & Downgrades
| Initiated | Goldman Sachs: Buy | 5/30/2025 |
| Maintains | Citigroup: Buy to Buy | 5/22/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 5/5/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/2/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/2/2025 |
| Maintains | Baird: Outperform to Outperform | 5/2/2025 |
Related Tickers
PODD Insulet Corporation
303.62
+0.46%
TNDM Tandem Diabetes Care, Inc.
20.92
-2.92%
SENS Senseonics Holdings, Inc.
0.5200
-0.46%
EW Edwards Lifesciences Corporation
75.89
+0.56%
ABT Abbott Laboratories
136.45
+0.86%
BSX Boston Scientific Corporation
98.56
-0.85%
MDT Medtronic plc
88.49
+0.49%
SYK Stryker Corporation
380.49
-0.15%
MASI Masimo Corporation
165.34
-1.00%
GMED Globus Medical, Inc.
60.20
-0.99%